CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

Journal:
Nature Medicine
Published:
Affiliations:
34
Authors:
38
Institutions Authors Share
Innovent Biologics, Inc., China
4.000000
0.11
Shandong Cancer Hospital, China
2.000000
0.05
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
2.000000
0.05
Fudan University Shanghai Cancer Center (FUSCC), China
2.000000
0.05
Fujian Cancer Hospital, China
1.000000
0.03
The First Affiliated Hospital, USTC, China
1.000000
0.03
Jinan Central Hospital, China
1.000000
0.03
Jiangxi Provincial Cancer Hospital, China
1.000000
0.03
Shanghai Cancer Institute (SCI) at Renji Hospital, SJTU, China
1.000000
0.03
Pindara Private Hospital, Australia
1.000000
0.03
The First Affiliated Hospital, Zhejiang University School of Medicine, China
1.000000
0.03
Hunan Cancer Hospital, China
1.000000
0.03
The Affiliated Hospital of Qingdao University, China
1.000000
0.03
Sun Yat-sen Memorial Hospital, SYSU, China
1.000000
0.03
Yijishan Hospital of Wannan Medical College, China
1.000000
0.03
First Affiliated Hospital, ZZU, China
1.000000
0.03
Zhejiang Cancer Hospital (ZJCH), China
1.000000
0.03
Zhejiang Provincial People's Hospital, China
1.000000
0.03
Henan Provincial People's Hospital, China
1.000000
0.03
General Hospital of Ningxia Medical University, China
1.000000
0.03
Anhui Provincial Cancer Hospital, China
1.000000
0.03
Jining First People's Hospital, China
1.000000
0.03
Shengjing Hospital of China Medical University, China
1.000000
0.03
Tianjin Medical University Cancer Institute and Hospital, TMU, China
1.000000
0.03
Drum Tower Hospital, China
1.000000
0.03
Cancer Institute and Hospital, CAMS & PUMC, China
1.000000
0.03
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China
1.000000
0.03
Tongji Hospital (TJH), HUST, China
1.000000
0.03
Hubei Cancer Hospital (HBCH), China
1.000000
0.03
Ningbo Medical Center Li Huili Hospital, China
1.000000
0.03
Sunshine Coast University Private Hospital, Australia
1.000000
0.03
The Kinghorn Cancer Centre (TKCC), Australia
0.333333
0.01
University of New South Wales (UNSW Sydney), Australia
0.333333
0.01
Garvan Institute of Medical Research, Australia
0.333333
0.01